{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:14Z","timestamp":1792791494200,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K22274"],"award-info":[{"award-number":["JP24K22274"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K02449"],"award-info":[{"award-number":["JP24K02449"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H05481"],"award-info":[{"award-number":["JP23H05481"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Foundation for Applied Enzymology Enzymology; MSD Life Science Foundation, the Public Interest Incorporated Foundation; SENSHIN Medical Research Foundation; The Cardiovascular Research Fund","id":[{"id":"https:\/\/ror.org\/021tj4g88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-025-00687-1","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T09:04:34Z","timestamp":1755594274000},"page":"1077-1093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Excessive HIF-1\u03b1 driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0394-8959","authenticated-orcid":false,"given":"Masatsugu","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1893-8171","authenticated-orcid":false,"given":"Masataka","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-3052","authenticated-orcid":false,"given":"Ko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kanamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko Deguchi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisho","family":"Kozakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko Shojima","family":"Isayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouji","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-1550","authenticated-orcid":false,"given":"Tomomi","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2100-8477","authenticated-orcid":false,"given":"Ken-ichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"687_CR1","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit. Care Med. 49, e1063\u2013e1143 (2021).","journal-title":"Crit. Care Med."},{"key":"687_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"687_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","volume":"46","author":"SJ Beesley","year":"2018","unstructured":"Beesley, S. J. et al. Septic cardiomyopathy. Crit Care Med 46, 625\u2013634 (2018).","journal-title":"Crit Care Med"},{"key":"687_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/cc7157","volume":"12","author":"J Blanco","year":"2008","unstructured":"Blanco, J. et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit. Care 12, R158 (2008).","journal-title":"Crit. Care"},{"key":"687_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1399-6576.1997.tb05514.x","volume":"110","author":"M Fink","year":"1997","unstructured":"Fink, M. Cytopathic hypoxia in sepsis. Acta Anaesthesiol. Scand. 110, 87\u201395 (1997).","journal-title":"Acta Anaesthesiol. Scand."},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0749-0704(05)70161-5","volume":"17","author":"MP Fink","year":"2001","unstructured":"Fink, M. P. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit. Care Clin. 17, 219\u2013237 (2001).","journal-title":"Crit. Care Clin."},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","volume":"27","author":"RS Hotchkiss","year":"1999","unstructured":"Hotchkiss, R. S. et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27, 1230\u20131251 (1999).","journal-title":"Crit. Care Med."},{"key":"687_CR8","first-page":"6","volume":"12","author":"GI van Boxel","year":"2012","unstructured":"van Boxel, G. I., Doherty, W. L. & Parmar, M. Cellular oxygen utilization in health and sepsis. Contin. Ed. Anaesth. Crit. Care Pain 12, 6 (2012).","journal-title":"Contin. Ed. Anaesth. Crit. Care Pain"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar, A. J., Wong, W. J. & Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294\u2013309 (2010).","journal-title":"Mol. Cell"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399\u2013408 (2012).","journal-title":"Cell"},{"key":"687_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cmet.2006.02.007","volume":"3","author":"MC Simon","year":"2006","unstructured":"Simon, M. C. Coming up for air: HIF-1 and mitochondrial oxygen consumption. Cell Metab. 3, 150\u2013151 (2006).","journal-title":"Cell Metab."},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L. & Denko, N. C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187\u2013197 (2006).","journal-title":"Cell Metab."},{"key":"687_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"JW Kim","year":"2006","unstructured":"Kim, J. W., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177\u2013185 (2006).","journal-title":"Cell Metab."},{"key":"687_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1253\/circj.CJ-19-1039","volume":"84","author":"H Deguchi","year":"2020","unstructured":"Deguchi, H. et al. Roxadustat markedly reduces myocardial ischemia reperfusion injury in mice. Circ. J. 84, 1028\u20131033 (2020).","journal-title":"Circ. J."},{"key":"687_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/CIRCRESAHA.117.305109","volume":"117","author":"T Bishop","year":"2015","unstructured":"Bishop, T. & Ratcliffe, P. J. HIF hydroxylase pathways in cardiovascular physiology and medicine. Circ. Res. 117, 65\u201379 (2015).","journal-title":"Circ. Res."},{"key":"687_CR16","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.jacc.2005.08.045","volume":"46","author":"M Kido","year":"2005","unstructured":"Kido, M. et al. Hypoxia-inducible factor 1-\u03b1 reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J. Am. Coll. Cardiol. 46, 2116\u20132124 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"687_CR17","doi-asserted-by":"publisher","first-page":"11185","DOI":"10.1074\/jbc.M110.186809","volume":"286","author":"M Holscher","year":"2011","unstructured":"Holscher, M. et al. Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury. J. Biol. Chem. 286, 11185\u201311194 (2011).","journal-title":"J. Biol. Chem."},{"key":"687_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.109.922427","volume":"122","author":"J Moslehi","year":"2010","unstructured":"Moslehi, J. et al. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation 122, 1004\u20131016 (2010).","journal-title":"Circulation"},{"key":"687_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/cvr\/cvs014","volume":"94","author":"M Holscher","year":"2012","unstructured":"Holscher, M. et al. Unfavourable consequences of chronic cardiac HIF-1\u03b1 stabilization. Cardiovasc Res. 94, 77\u201386 (2012).","journal-title":"Cardiovasc Res."},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"e11693","DOI":"10.1371\/journal.pone.0011693","volume":"5","author":"R Bekeredjian","year":"2010","unstructured":"Bekeredjian, R. et al. Conditional HIF-1\u03b1 expression produces a reversible cardiomyopathy. PLoS ONE 5, e11693 (2010).","journal-title":"PLoS ONE"},{"key":"687_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","volume":"32","author":"AF McGettrick","year":"2020","unstructured":"McGettrick, A. F. & O\u2019Neill, L. A. J. The role of HIF in immunity and inflammation. Cell Metab. 32, 524\u2013536 (2020).","journal-title":"Cell Metab."},{"key":"687_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04885-4","volume":"28","author":"H Ruan","year":"2024","unstructured":"Ruan, H., Zhang, Q., Zhang, Y. P., Li, S. S. & Ran, X. Unraveling the role of HIF-1\u03b1 in sepsis: from pathophysiology to potential therapeutics-a narrative review. Crit. Care 28, 100 (2024).","journal-title":"Crit. Care"},{"key":"687_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06905","volume":"453","author":"J Rius","year":"2008","unstructured":"Rius, J. et al. NF-\u03baB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1\u03b1. Nature 453, 807\u2013811 (2008).","journal-title":"Nature"},{"key":"687_CR24","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","volume":"17","author":"YJ Jung","year":"2003","unstructured":"Jung, Y. J., Isaacs, J. S., Lee, S., Trepel, J. & Neckers, L. IL-1\u03b2-mediated up-regulation of HIF-1\u03b1 via an NF\u03baB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 17, 2115\u20132117 (2003).","journal-title":"FASEB J."},{"key":"687_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173817","volume":"894","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. IL-6 promotes nuclear translocation of HIF-1\u03b1 to aggravate chemoresistance of ovarian cancer cells. Eur. J. Pharmacol. 894, 173817 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"687_CR26","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1091\/mbc.e02-09-0598","volume":"14","author":"J Zhou","year":"2003","unstructured":"Zhou, J., Schmid, T. & Brune, B. Tumor necrosis factor-\u03b1 causes accumulation of a ubiquitinated form of hypoxia inducible factor-1\u03b1 through a nuclear factor-\u03baB-dependent pathway. Mol. Biol. Cell 14, 2216\u20132225 (2003).","journal-title":"Mol. Biol. Cell"},{"key":"687_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nprot.2014.018","volume":"9","author":"JK Salabei","year":"2014","unstructured":"Salabei, J. K., Gibb, A. A. & Hill, B. G. Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis. Nat. Protoc. 9, 421\u2013438 (2014).","journal-title":"Nat. Protoc."},{"key":"687_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.niox.2019.04.005","volume":"88","author":"JJ Poderoso","year":"2019","unstructured":"Poderoso, J. J., Helfenberger, K. & Poderoso, C. The effect of nitric oxide on mitochondrial respiration. Nitric Oxide 88, 61\u201372 (2019).","journal-title":"Nitric Oxide"},{"key":"687_CR29","doi-asserted-by":"publisher","first-page":"50081","DOI":"10.1074\/jbc.M201095200","volume":"277","author":"XH Liu","year":"2002","unstructured":"Liu, X. H. et al. Prostaglandin E2 induces hypoxia-inducible factor-1\u03b1 stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. 277, 50081\u201350086 (2002).","journal-title":"J. Biol. Chem."},{"key":"687_CR30","doi-asserted-by":"publisher","first-page":"36567","DOI":"10.1074\/jbc.M504280200","volume":"280","author":"TC Chang","year":"2005","unstructured":"Chang, T. C. et al. Stabilization of hypoxia-inducible factor-1\u03b1 by prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells. J. Biol. Chem. 280, 36567\u201336574 (2005).","journal-title":"J. Biol. Chem."},{"key":"687_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jcb.21801","volume":"105","author":"L Liu","year":"2008","unstructured":"Liu, L. & Clipstone, N. A. Prostaglandin F2\u03b1 induces the normoxic activation of the hypoxia-inducible factor-1 transcription factor in differentiating 3T3-L1 preadipocytes: potential role in the regulation of adipogenesis. J. Cell. Biochem. 105, 89\u201398 (2008).","journal-title":"J. Cell. Biochem."},{"key":"687_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/cbt.8.1.7079","volume":"8","author":"I Stasinopoulos","year":"2009","unstructured":"Stasinopoulos, I., O\u2019Brien, D. R. & Bhujwalla, Z. M. Inflammation, but not hypoxia, mediated HIF-1\u03b1 activation depends on COX-2. Cancer Biol. Ther. 8, 31\u201335 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"687_CR33","doi-asserted-by":"publisher","first-page":"25244","DOI":"10.1074\/jbc.M113.489708","volume":"288","author":"SJ Lee","year":"2013","unstructured":"Lee, S. J. et al. Regulation of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) by lysophosphatidic acid is dependent on interplay between p53 and Kruppel-like factor 5. J. Biol. Chem. 288, 25244\u201325253 (2013).","journal-title":"J. Biol. Chem."},{"key":"687_CR34","doi-asserted-by":"publisher","first-page":"e0137513","DOI":"10.1371\/journal.pone.0137513","volume":"10","author":"YR No","year":"2015","unstructured":"No, Y. R., Lee, S. J., Kumar, A. & Yun, C. C. HIF1\u03b1-Induced by lysophosphatidic acid is stabilized via interaction with MIF and CSN5. PLoS ONE 10, e0137513 (2015).","journal-title":"PLoS ONE"},{"key":"687_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","volume":"3","author":"J Seo","year":"2020","unstructured":"Seo, J. et al. Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun Biol. 3, 638 (2020).","journal-title":"Commun Biol"},{"key":"687_CR36","doi-asserted-by":"publisher","first-page":"e20211291","DOI":"10.1084\/jem.20211291","volume":"219","author":"Y Otake-Kasamoto","year":"2022","unstructured":"Otake-Kasamoto, Y. et al. Lysophosphatidylserines derived from microbiota in Crohn\u2019s disease elicit pathological Th1 response. J. Exp. Med. 219, e20211291 (2022).","journal-title":"J. Exp. Med."},{"key":"687_CR37","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0092-8674(95)90015-2","volume":"81","author":"M MacPhee","year":"1995","unstructured":"MacPhee, M. et al. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81, 957\u2013966 (1995).","journal-title":"Cell"},{"key":"687_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.30.526342","author":"M Takahama","year":"2023","unstructured":"Takahama, M. et al. Organism-wide analysis of sepsis reveals mechanisms of systemic inflammation. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.01.30.526342 (2023).","journal-title":"bioRxiv"},{"key":"687_CR39","doi-asserted-by":"publisher","first-page":"ra56","DOI":"10.1126\/scisignal.aaf0583","volume":"9","author":"JW Bullen","year":"2016","unstructured":"Bullen, J. W. et al. Protein kinase A-dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1. Sci. Signal 9, ra56 (2016).","journal-title":"Sci. Signal"},{"key":"687_CR40","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/ijms23031083","volume":"23","author":"LF Li","year":"2022","unstructured":"Li, L. F. et al. Reduction in ventilation-induced diaphragmatic mitochondrial injury through hypoxia-inducible factor 1\u03b1 in a murine endotoxemia model. Int. J. Mol. Sci. 23, 1083 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"687_CR41","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05602","volume":"446","author":"M Sano","year":"2007","unstructured":"Sano, M. et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446, 444\u2013448 (2007).","journal-title":"Nature"},{"key":"687_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.it.2020.02.003","volume":"41","author":"VP van Hensbergen","year":"2020","unstructured":"van Hensbergen, V. P., Wu, Y., van Sorge, N. M. & Touqui, L. Type IIA secreted phospholipase A2 in host defense against bacterial infections. Trends Immunol. 41, 313\u2013326 (2020).","journal-title":"Trends Immunol"},{"key":"687_CR43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bbalip.2018.08.017","volume":"1864","author":"E Dore","year":"2019","unstructured":"Dore, E. & Boilard, E. Roles of secreted phospholipase A(2) group IIA in inflammation and host defense. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 1864, 789\u2013802 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"687_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149236","volume":"131","author":"JM Snider","year":"2021","unstructured":"Snider, J. M. et al. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J. Clin. Invest. 131, e149236 (2021).","journal-title":"J. Clin. Invest."},{"key":"687_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-pathol-050420-025929","volume":"17","author":"K Kano","year":"2022","unstructured":"Kano, K., Aoki, J. & Hla, T. Lysophospholipid mediators in health and disease. Annu. Rev. Pathol. 17, 459\u2013483 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"687_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","volume":"100","author":"I Kimura","year":"2020","unstructured":"Kimura, I., Ichimura, A., Ohue-Kitano, R. & Igarashi, M. Free fatty acid receptors in health and disease. Physiol. Rev. 100, 171\u2013210 (2020).","journal-title":"Physiol. Rev."},{"key":"687_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70799-0","volume":"10","author":"EH Lee","year":"2020","unstructured":"Lee, E. H. et al. Diagnosis and mortality prediction of sepsis via lysophosphatidylcholine 16:0 measured by MALDI-TOF MS. Sci. Rep. 10, 13833 (2020).","journal-title":"Sci. Rep."},{"key":"687_CR48","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10096-011-1505-6","volume":"31","author":"WH Cho","year":"2012","unstructured":"Cho, W. H. et al. Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1805\u20131810 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"687_CR49","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice, T. W. et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit. Care Med. 38, 1685\u20131694 (2010).","journal-title":"Crit. Care Med"},{"key":"687_CR50","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1056\/NEJM199703273361303","volume":"336","author":"GR Bernard","year":"1997","unstructured":"Bernard, G. R. et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis study group. N. Engl. J. Med. 336, 912\u2013918 (1997).","journal-title":"N. Engl. J. Med."},{"key":"687_CR51","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0959-440X(01)00277-9","volume":"11","author":"RG Kurumbail","year":"2001","unstructured":"Kurumbail, R. G., Kiefer, J. R. & Marnett, L. J. Cyclooxygenase enzymes: catalysis and inhibition. Curr. Opin. Struct. Biol. 11, 752\u2013760 (2001).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"687_CR52","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1097\/01.CCM.0000171540.54520.69","volume":"33","author":"BG Zeiher","year":"2005","unstructured":"Zeiher, B. G. et al. LY315920NA\/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit. Care Med. 33, 1741\u20131748 (2005).","journal-title":"Crit. Care Med."},{"key":"687_CR53","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1097\/01.CCM.0000189943.60945.77","volume":"33","author":"RJ Levy","year":"2005","unstructured":"Levy, R. J. et al. Evidence of myocardial hibernation in the septic heart. Crit. Care Med. 33, 2752\u20132756 (2005).","journal-title":"Crit. Care Med."},{"key":"687_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.shk.0000235089.30550.2d","volume":"28","author":"RJ Levy","year":"2007","unstructured":"Levy, R. J. Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock 28, 24\u201328 (2007).","journal-title":"Shock"},{"key":"687_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10409238.2013.838205","volume":"49","author":"VL Dengler","year":"2014","unstructured":"Dengler, V. L., Galbraith, M. & Espinosa, J. M. Transcriptional regulation by hypoxia inducible factors. Crit. Rev. Biochem. Mol. Biol. 49, 1\u201315 (2014).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"687_CR56","first-page":"4010","volume":"60","author":"HE Ryan","year":"2000","unstructured":"Ryan, H. E. et al. Hypoxia-inducible factor-1\u03b1 is a positive factor in solid tumor growth. Cancer Res. 60, 4010\u20134015 (2000).","journal-title":"Cancer Res."},{"key":"687_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI119509","volume":"100","author":"R Agah","year":"1997","unstructured":"Agah, R. et al. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100, 169\u2013179 (1997).","journal-title":"J. Clin. Invest."},{"key":"687_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11498","volume":"7","author":"S Honda","year":"2016","unstructured":"Honda, S. et al. Marginal zone B cells exacerbate endotoxic shock via interleukin-6 secretion induced by Fc\u03b1\/muR-coupled TLR4 signalling. Nat. Commun. 7, 11498 (2016).","journal-title":"Nat. Commun."},{"key":"687_CR59","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010347","volume":"16","author":"S Furusawa","year":"2023","unstructured":"Furusawa, S. et al. Cardiac autoantibodies against cardiac troponin I in post-myocardial infarction heart failure: evaluation in a novel murine model and applications in therapeutics. Circ. Heart. Fail. 16, e010347 (2023).","journal-title":"Circ. Heart. Fail."},{"key":"687_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132747","volume":"5","author":"T Tadokoro","year":"2020","unstructured":"Tadokoro, T. et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight 5, e132747 (2020).","journal-title":"JCI Insight"},{"key":"687_CR61","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.020895","volume":"10","author":"M Ikeda","year":"2021","unstructured":"Ikeda, M. et al. Excessive hypoxia-inducible factor-1\u03b1 expression induces cardiac rupture via p53-dependent apoptosis after myocardial infarction. J. Am. Heart Assoc. 10, e020895 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"687_CR62","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jacbts.2022.03.012","volume":"7","author":"HD Miyamoto","year":"2022","unstructured":"Miyamoto, H. D. et al. Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury. JACC Basic Transl. Sci. 7, 800\u2013819 (2022).","journal-title":"JACC Basic Transl. Sci."},{"key":"687_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abn8017","volume":"15","author":"K Abe","year":"2022","unstructured":"Abe, K. et al. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis. Sci. Signal 15, eabn8017 (2022).","journal-title":"Sci. Signal"},{"key":"687_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/srep15881","volume":"5","author":"M Ikeda","year":"2015","unstructured":"Ikeda, M. et al. The Akt\u2013mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload. Sci. Rep. 5, 15881 (2015).","journal-title":"Sci. Rep."},{"key":"687_CR65","doi-asserted-by":"publisher","first-page":"ajpheart 00044","DOI":"10.1152\/ajpheart.00044.2016","volume":"311","author":"T Inoue","year":"2016","unstructured":"Inoue, T. et al. Twinkle overexpression prevents cardiac rupture after myocardial infarction by alleviating impaired mitochondrial biogenesis. Am. J. Physiol. Heart. Circ. Physiol. 311, ajpheart 00044 02016 (2016).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"687_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10557-020-07123-5","volume":"36","author":"M Ikeda","year":"2021","unstructured":"Ikeda, M. et al. Heart rate reduction with ivabradine prevents cardiac rupture after myocardial infarction in mice. Cardiovasc. Drugs Ther. 36, 257\u2013262 (2021).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"687_CR67","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031219","volume":"13","author":"K Ishimaru","year":"2024","unstructured":"Ishimaru, K. et al. Deferasirox targeting ferroptosis synergistically ameliorates myocardial ischemia reperfusion injury in conjunction with cyclosporine A. J. Am. Heart Assoc. 13, e031219 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"687_CR68","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1152\/ajpcell.00090.2016","volume":"312","author":"S Arai","year":"2017","unstructured":"Arai, S. et al. Functional loss of DHRS7C induces intracellular Ca2+ overload and myotube enlargement in C2C12 cells via calpain activation. Am. J. Physiol. Cell Physiol. 312, C29\u2013C39 (2017).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"687_CR69","doi-asserted-by":"publisher","first-page":"e0119687","DOI":"10.1371\/journal.pone.0119687","volume":"10","author":"M Ikeda","year":"2015","unstructured":"Ikeda, M. et al. Overexpression of TFAM or twinkle increases mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress. PLoS ONE 10, e0119687 (2015).","journal-title":"PLoS ONE"},{"key":"687_CR70","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.009366","volume":"15","author":"M Ikeda","year":"2022","unstructured":"Ikeda, M. et al. Immunomodulatory cell therapy using \u03b1GalCer-pulsed dendritic cells ameliorates heart failure in a murine dilated cardiomyopathy model. Circ. Heart. Fail. 15, e009366 (2022).","journal-title":"Circ. Heart. Fail."},{"key":"687_CR71","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A simplified, langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ. Res. 119, 909\u2013920 (2016).","journal-title":"Circ. Res."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00687-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T14:02:31Z","timestamp":1757944951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00687-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":71,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1038\/s44161-025-00687-1","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}